ATE395600T1 - Verfahren zur diagnose von knochenmetastasen aus malignen tumoren - Google Patents

Verfahren zur diagnose von knochenmetastasen aus malignen tumoren

Info

Publication number
ATE395600T1
ATE395600T1 AT99938547T AT99938547T ATE395600T1 AT E395600 T1 ATE395600 T1 AT E395600T1 AT 99938547 T AT99938547 T AT 99938547T AT 99938547 T AT99938547 T AT 99938547T AT E395600 T1 ATE395600 T1 AT E395600T1
Authority
AT
Austria
Prior art keywords
bone metastasis
malignant tumors
diagnosing bone
marker
reflects
Prior art date
Application number
AT99938547T
Other languages
English (en)
Inventor
Etsuro Ogata
Mitsuru Koizumi
Shunji Takahashi
Original Assignee
Etsuro Ogata
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Etsuro Ogata filed Critical Etsuro Ogata
Application granted granted Critical
Publication of ATE395600T1 publication Critical patent/ATE395600T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
AT99938547T 1998-08-21 1999-08-20 Verfahren zur diagnose von knochenmetastasen aus malignen tumoren ATE395600T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23614698 1998-08-21

Publications (1)

Publication Number Publication Date
ATE395600T1 true ATE395600T1 (de) 2008-05-15

Family

ID=16996446

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938547T ATE395600T1 (de) 1998-08-21 1999-08-20 Verfahren zur diagnose von knochenmetastasen aus malignen tumoren

Country Status (7)

Country Link
US (1) US7632486B1 (de)
EP (1) EP1107006B1 (de)
JP (1) JP4420565B2 (de)
AT (1) ATE395600T1 (de)
AU (1) AU5302599A (de)
DE (1) DE69938729D1 (de)
WO (1) WO2000011480A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1882946T1 (sl) 2003-12-23 2010-06-30 Hoffmann La Roche Postopek za ugotavljanje revmatoidnega artritisa z merjenjem anti CCP in interlevkina
EP2225559B8 (de) * 2007-12-28 2016-12-21 F. Hoffmann-La Roche AG Beurteilung physiologischer bedingungen
US20140044736A1 (en) * 2011-03-08 2014-02-13 The Johns Hopkins University Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
MX2013012695A (es) 2011-05-02 2014-03-27 Exelixis Inc Metodo para el tratamiento del cancer y el dolor por cancer de hueso.
CA2987372C (en) * 2015-06-04 2024-02-20 Nihon Medi-Physics Co., Ltd. Diagnostic imaging agent for early bone metastasis from cancer
ES2967857T3 (es) * 2018-08-03 2024-05-06 Cytogen Inc Composición para el diagnóstico de la metástasis ósea del cáncer y kit que la contiene
JP7080534B2 (ja) * 2018-08-03 2022-06-06 サイトジェン インコーポレーテッド 癌の骨転移診断用組成物およびこれを含むキット
EP4317172A4 (de) * 2021-03-24 2025-03-05 Sekisui Medical Co., Ltd. Immunologisches analyseverfahren für typ-i-kollagen-c-terminales tlopeptid
CN117316426B (zh) * 2023-09-12 2026-01-20 上海市第六人民医院 基于骨转移特异性骨标志物的肿瘤骨转移预测系统及方法
CN121393909B (zh) * 2025-12-26 2026-03-24 海南省人民医院 基于骨转移特异性骨标志物的肿瘤骨转移预测系统及方法

Also Published As

Publication number Publication date
US7632486B1 (en) 2009-12-15
JP4420565B2 (ja) 2010-02-24
EP1107006A4 (de) 2002-03-06
DE69938729D1 (de) 2008-06-26
WO2000011480A1 (fr) 2000-03-02
EP1107006A1 (de) 2001-06-13
AU5302599A (en) 2000-03-14
EP1107006B1 (de) 2008-05-14

Similar Documents

Publication Publication Date Title
DE69738077D1 (de) Tiermodelle für die menschliche prostatakrebsfortschreitung
ATE294595T1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
DE69730820D1 (de) Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel
DE69842094D1 (de) Zusammensetzungen und Verfahren zur Behandlung primärer und metastatischer Erkrankungen mithilfe Arsentrioxid
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
ATE345387T1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
ATE469242T1 (de) Zusammensetzungen und methoden zur identifizierung und zum targeting von krebszellen aus dem verdauungskanal
EP1257287A4 (de) Verbindungen und methoden zur frühdiagnose von eierstockkrebs
ATE522623T1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von lungentumoren
EP0967015A3 (de) Verwendung von Ferrocenylliganden zur katalytischen enantioselektiven Hydrierung
ATE395600T1 (de) Verfahren zur diagnose von knochenmetastasen aus malignen tumoren
DE69927688D1 (de) Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs
AU3392901A (en) Proteins
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
DE60113968D1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
WO2003037257A3 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
ATE435284T1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
ATE329597T1 (de) Die verwendung von einer 4- pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren
ATE337020T1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
DE10296200D2 (de) Verfahren zur Diagnose von Brustkrebserkrankungen, zugehörige Peptide und deren Verwendungen
DE69931644D1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
ATE240352T1 (de) Komplexverbindungen zur diagnose von gefässerkrankungen
ATE546544T1 (de) Verfahren zur diagnose und behandlung von lungenkrebs
ATE423462T1 (de) Verfahren zur diagnose von prostatakrebs
WO2002034282A3 (en) Mammary secreted protein 36 (msp36) for cancer treatment and diagnosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties